Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

The Zacks Analyst Blog Highlights: UnitedHealth, Pacira, Turning Point, Coca-Cola And Sempra

Published 03/13/2020, 12:14 AM
Updated 07/09/2023, 06:31 AM

For Immediate Release

Chicago, IL – March 13, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include UnitedHealth Group Inc. (NYSE:UNH) , Pacira BioSciences, Inc. (NASDAQ:PCRX) , Turning Point Brands, Inc. (NYSE:TPB) , The Coca-Cola Company (NYSE:KO) and Sempra Energy (NYSE:SRE) .

Here are highlights from Thursday’s Analyst Blog:

5 Best Stocks to Buy in a Coronavirus-Led Bear Market

It seems the U.S. stock market’s bull run is coming to an end. The Dow has already plunged into the bear-market territory for the first time in a decade. And the blue-chip index’s descend from a recent peak has been the fastest since the Great Depression. This time, it just took 19 trading days for the 30-stock average to enter bear market, while in November 1931, when the Great Depression was evolving, the index took a brisk 15 days to pullback at least 20%.

Other major benchmarks, including the broader S&P 500, are also headed for a bear market. What’s more, the period of a typical bear market has a propensity to be pretty lengthy. On average, bear market for the Dow and the S&P 500 lasts for 206 and 146 trading days, respectively, per data compiled by Dow Jones Market Data. U.S. stocks, by the way, had already slipped into correction mode in February.

But what’s dragging stocks into a bear market? Investors are particularly tensed about the economic impact of the fast spread of coronavirus across the globe. Several companies have already raised alarm bells about the outbreak weighing on their earnings, and supply chains getting disrupted. And it will certainly lead to both a demand and a supply shock for the global economy, as it mostly erupted in China. After all, China is one of the world’s largest exporters and importers of goods.

Top equity strategist at Goldman Sachs (NYSE:GS), David Kostin, thus expects S&P 500 companies to see a collective drop of almost 15% in their earnings for the second quarter, and a drop of around 12% in the third.

Meanwhile, President Trump failed to quell worries about the possible economic slowdown from the coronavirus. In an attempt the curb the negative impact of the virus on the economy, he announced travel restrictions with Europe, and promised to offer “a payroll tax cut or relief” to both business houses and hourly wage earners.

But his proposals were received with skepticism from both Democrats and Republicans, as they were mostly looking for a more robust fiscal policy to counter slowing economic growth. At the same time, it’s quite evident, not all his proposed plans are likely to get passed in the Democratic-controlled House of Representatives. In fact, U.S. Treasury Secretary Steven Mnuchin did mention that it will take some time for the economic stimulus measures to get through Congress.

Recently, the World Health Organization declared the coronavirus outbreak a global pandemic. After all, governments from Italy to California have imposed bans on public gatherings in a move to restrict the spread of the illness. And this restriction in consumer movement will ultimately impact economic growth worldwide.

Which Stocks to Buy in a Bear Market?

No doubt, when the broader market nosedives, companies that offer big-ticket items like autos, machinery, high technology and home improvement items tend to take a beating. After all, they are cyclical stocks and do well when the economy is in a sound condition. But when the market is tanking and the economy is feared to enter a recession, it pays to switch to defensive sectors like healthcare, consumer staples and utilities. Stocks from these sectors are generally non-cyclical, or companies whose business performance and sales are not highly correlated with the activities in the larger market.

Health is no doubt a priority, and consumers will continue to avail healthcare products and services in difficult economic times. Similarly, food, beverage and tobacco companies are true defensive plays as demand for such staple stocks remains unaltered during market gyrations. Utilities too are deemed defensive stocks as electricity, gas and water are essentials.

5 Solid Choices

We have selected five solid stocks from the aforesaid areas that should make meaningful additions to your portfolio. These stocks flaunt a Zacks Rank #1 (Strong Buy) or 2 (Buy).

UnitedHealth Group Inc.operates as a diversified health care company in the United States. The company has a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has moved 0.1% up over the past 60 days. The company’s expected earnings growth rate for the next quarter and current year is 16.7% and 9%, respectively.

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions. The company has a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has risen 19.8% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 109.1% and 52.1%, respectively.

Turning Point Brands, Inc. provides tobacco products in the United States. The company has a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings has climbed 5.1% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is 9.3% and 10.2%, respectively. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Coca-Cola Companyhas a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has moved 0.4% north over the past 60 days. The company’s expected earnings growth rate for the next quarter and current year is 4.8% and 6.6%, respectively.

Sempra Energydevelops and operates energy infrastructure. The company has a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has risen 3.2% over the past 60 days. The company’s expected earnings growth rate for the next quarter and current year is 12.7% and 5.2%, respectively.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Join us on Facebook (NASDAQ:FB): http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.



UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Sempra Energy (SRE): Free Stock Analysis Report

Coca-Cola Company (The) (KO): Free Stock Analysis Report

Pacira Pharmaceuticals, Inc. (PCRX): Free Stock Analysis Report

Turning Point Brands, Inc. (TPB): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.